Therapy of Osteoporosis in Men with Teriparatide
Osteoanabolic therapy is an attractive therapeutic option for men with osteoporosis because it directly stimulates bone formation, an action not shared by any antiresorptive drug. Teriparatide (recombinant human PTH(1-34)) and PTH(1-84) are available in many countries but PTH(1-84) is not available...
Saved in:
Main Authors: | Natalie E. Cusano, Aline G. Costa, Barbara C. Silva, John P. Bilezikian |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2011-01-01
|
Series: | Journal of Osteoporosis |
Online Access: | http://dx.doi.org/10.4061/2011/463675 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors Associated with Persistence with Teriparatide Therapy: Results from the DANCE Observational Study
by: Deborah T. Gold, et al.
Published: (2011-01-01) -
Osteoporosis in Men with Diabetes Mellitus
by: Claire Issa, et al.
Published: (2011-01-01) -
Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study
by: K. Aloumanis, et al.
Published: (2011-01-01) -
The Evidence for Efficacy of Osteoporosis Treatment in Men with Primary Osteoporosis: A Systematic Review and Meta-Analysis of Antiresorptive and Anabolic Treatment in Men
by: Peter Schwarz, et al.
Published: (2011-01-01) -
Effects of Teriparatide on Bone Mineral Density and Prevention of Fragility Fractures in Saudi Arabian Subjects with Osteoporosis: A Two-Year Clinical Study from a Single Center
by: Mir Sadat-Ali, et al.
Published: (2022-01-01)